Showing results (1331-1340 of 1,507) with videos related to

Sort By:
Pageof 151
Pediatric Blood & Cancer|May 6, 2006
A study to determine the minimum volume of blood necessary to be discarded from a central venous catheter before a valid sample is obtained in children with cancerM Cole, L Price, A Parry, et al.
Accident; Analysis and Prevention|May 4, 2013
Development and evaluation of a driving observation schedule (DOS) to study everyday driving performance of older driversZ Vlahodimitrakou, J L Charlton, J Langford, et al.
Chronobiology International|October 2, 2019
Is 24-hour energy intake greater during night shift compared to non-night shift patterns? A systematic reviewElizabeth A Cayanan, Nadine A B Eyre, Vickie Lao, et al.
Journal of Sleep Research|March 2, 2019
Intra-individual stability of NREM sleep quantitative EEG measures in obstructive sleep apneaJoseph J Y Poon, Julia L Chapman, Keith K H Wong, et al.
The Pediatric Infectious Disease Journal|December 20, 2012
Changes in patterns of hospitalized children with varicella and of associated varicella genotypes after introduction of varicella vaccine in AustraliaHelen S Marshall, Peter McIntyre, Peter Richmond, et al.
Stroke|July 17, 2012
Impact of acute ischemic stroke treatment in patients >80 years of age: the specialized program of translational research in acute stroke (SPOTRIAS) consortium experienceJoshua Z Willey, Santiago Ortega-Gutierrez, Nils Petersen, et al.
The Pediatric Infectious Disease Journal|June 22, 2012
Safety and immunogenicity of a meningococcal B bivalent rLP2086 vaccine in healthy toddlers aged 18-36 months: a phase 1 randomized-controlled clinical trialHelen S Marshall, Peter C Richmond, Michael D Nissen, et al.
Investigational New Drugs|September 14, 2011
Therapeutic reactivation of mutant p53 protein by quinazoline derivativesHamish S Sutherland, In Young Hwang, Elaine S Marshall, et al.
The Pediatric Infectious Disease Journal|August 6, 2011
Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted vaccine coadministered with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine and/or meningococcal conjugate vaccine to healthy girls 11 to 18 years of age: results from a randomized open trialCosette M Wheeler, Bryan M Harvey, Michael E Pichichero, et al.
Pediatrics|February 3, 2006
A combination measles, mumps, rubella, and varicella vaccine (ProQuad) given to 4- to 6-year-old healthy children vaccinated previously with M-M-RII and VarivaxKeith S Reisinger, Michelle L Hoffman Brown, Jin Xu, et al.
Pageof 151